JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Randall C. Starling
Patrick M. McCarthy
James B. Young
Nicholas Smedira
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Neill, J. O.
Right arrow Articles by Chung, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Neill, J. O.
Right arrow Articles by Chung, M. K.

J Thorac Cardiovasc Surg 2005;130:1250-1256
© 2005 The American Association for Thoracic Surgery


Surgery for Acquired Cardiovascular Disease

Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery

James O. O'Neill, MB, FRCPI a , 1 , Randall C. Starling, MD, MPH, FACC a , Yaariv Khaykin, MD b , Patrick M. McCarthy, MD c , James B. Young, MD, MPH, FACC a , Melanie Hail, RN d , Nancy M. Albert, PhD, RN d , Nicholas Smedira, MD c , Mina K. Chung, MD, FACC b , *

a Department of Cardiovascular Medicine, Section of Heart Failure and Cardiac Transplant Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio.
b Department of Cardiovascular Medicine, Section of Cardiac Electrophysiology and Pacing, The Cleveland Clinic Foundation, Cleveland, Ohio.
c Department of Cardiothoracic Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio.
d Department of Cardiovascular Medicine, Kaufman Center for Heart Failure, The Cleveland Clinic Foundation, Cleveland, Ohio.

Received for publication February 17, 2005; revisions received June 27, 2005; accepted for publication June 30, 2005.

* Address for reprints: Mina K. Chung, MD, FACC, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Desk F15, 9500 Euclid Ave, Cleveland, OH 44195 (Email: Chungm{at}ccf.org).

OBJECTIVE: Left ventricular reconstruction is performed in patients with ischemic cardiomyopathy and akinetic or dyskinetic left ventricular regions. These patients may remain at risk for malignant ventricular arrhythmias and hence may benefit from prophylactic implantable cardioverter-defibrillators. Specific guidelines for electrophysiologic testing and implantable cardioverter-defibrillator implantation in patients undergoing left ventricular reconstruction are lacking. We aimed to assess the residual risk and timing of ventricular arrhythmias after left ventricular reconstruction to determine whether electrophysiologic risk stratification or implantable cardioverter-defibrillator implantation can be safely deferred.

METHODS: Data were prospectively gathered on 217 consecutive patients with left ventricular ejection fractions less than 40% undergoing left ventricular reconstruction at our institution from 1997 to 2002. Patients were divided into 3 groups: group 1, implantable cardioverter-defibrillator present before surgery; group 2, implantable cardioverter-defibrillator implanted early after surgery; and group 3, no implantable cardioverter-defibrillator implanted. End points were all-cause mortality (censored for cardiac transplantation) and appropriate implantable cardioverter-defibrillator therapies.

RESULTS: Of 217 patients (mean age, 61 ± 10 years [mean ± SD]), survival after a median follow-up of 381 days was 90%. Electrophysiologic studies successfully identified patients at low risk. Appropriate implantable cardioverter-defibrillator therapies occurred in 20% of group 1 and 12% of group 2. The median time to the first implantable cardioverter-defibrillator therapy from the time of left ventricular reconstruction was 43 days, and most first therapies (67%) occurred within the first 63 days.

CONCLUSIONS: The early event rates (occurring in the first 90 days after left ventricular reconstruction) support the use of predischarge electrophysiologic studies, implantation of implantable cardioverter-defibrillators before discharge from the hospital, or both.



Abbreviations and Acronyms CABG = coronary artery bypass grafting; EP = electrophysiologic; ICD = implantable cardioverter-defibrillator; LVEF = left ventricular ejection fraction; LVR = left ventricular reconstruction; MADIT = Multicenter Automatic Defibrillator Implantation Trial; STICH = Surgical Treatments for IsChemic Heart Failure





This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
P. Klein, J. J. Bax, L. J. Shaw, H. H.H. Feringa, M. I.M. Versteegh, R. A.E. Dion, and R. J.M. Klautz
Early and late outcome of left ventricular reconstruction surgery in ischemic heart disease
Eur. J. Cardiothorac. Surg., December 1, 2008; 34(6): 1149 - 1157.
[Abstract] [Full Text] [PDF]


Home page
MMCTSHome page
D. Lindblom, A. Albage, and U. Sartipy
Surgery for ventricular tachycardia in patients undergoing surgical ventricular restoration
MMCTS, December 17, 2007; 2007(1217): 2816.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Di Donato, M. Sabatier, L. Menicanti, and V. Dor
Incidence of ventricular arrhythmias after left ventricular reconstructive surgery
J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 289 - 291.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. O. O'Neill, R. C. Starling, and M. K. Chung
Reply to Di Donato and colleagues.
J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 292 - 293.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. O. O'Neill, R. C. Starling, P. M. McCarthy, N. M. Albert, B. W. Lytle, J. Navia, J. B. Young, and N. Smedira
The impact of left ventricular reconstruction on survival in patients with ischemic cardiomyopathy
Eur. J. Cardiothorac. Surg., November 1, 2006; 30(5): 753 - 759.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Buckberg
Editorial comment: Left ventricular reconstruction for dilated ischemic cardiomyopathy: biology, registry, randomization, and credibility
Eur. J. Cardiothorac. Surg., November 1, 2006; 30(5): 759 - 761.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
U. Sartipy, A. Albage, and D. Lindblom
Implantable cardioverter-defibrillator after left ventricular reconstruction?
J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1210 - 1211.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The American Association for Thoracic Surgery.